A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma

Mise à jour : Il y a 4 ans
Référence : NCT00444782

Femme et Homme

Extrait

The purpose of this study is to investigate the efficacy of GV1001 in locally advanced or metastatic HCC. Also the safety of GV1001 and immunogenicity will be evaluated.


Critère d'inclusion

  • Carcinoma, hepatocellular

Liens